These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 13412752)

  • 1. Inhibition of glutamic dehydrogenase of rat liver mitochondria by the carcinogen, N-2-fluorenyldiacetamide.
    KIELLEY RK
    Biochim Biophys Acta; 1957 Feb; 23(2):447. PubMed ID: 13412752
    [No Abstract]   [Full Text] [Related]  

  • 2. On the nature of the inhibition of glutamate oxidation by the carcinogen, N-2-fluorenyldiacetamide.
    KIELLEY RK
    J Biol Chem; 1957 Jul; 227(1):91-100. PubMed ID: 13449056
    [No Abstract]   [Full Text] [Related]  

  • 3. The mechanism underlying the inhibition of the liver mitochondrial oxidation of glutamate by the carcinogen N-2-fluorenylacetamide.
    EMMELOT P
    Biochim Biophys Acta; 1957 Mar; 23(3):668-9. PubMed ID: 13426193
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of glutamate oxidation by fluorene carcinogens in a phosphorylating mitochondrial system.
    KIELLEY RK
    Biochim Biophys Acta; 1956 Sep; 21(3):574-5. PubMed ID: 13363966
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of DPN on the inhibition of rat liver 3-hydroxyanthranilic acid oxidase by 2-acetylaminofluorene and N-2-fluorenyldiacetamide.
    QUAGLIARIELLO E; AURICCHIO S; RINALDI E; RUBINO A
    Clin Chim Acta; 1959 May; 4(3):450-3. PubMed ID: 13663252
    [No Abstract]   [Full Text] [Related]  

  • 6. On the acylation of the carcinogen 2-amino-fluorene by rat liver in vitro.
    NAGASAWA HT; GUTMANN HR
    Biochim Biophys Acta; 1957 Jun; 24(3):631-2. PubMed ID: 13436489
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on 4-dimethylaminoazo-benzene-induced hepatoma in rats. IV. Inhibition of xanthine dehydrogenase activity by a 4-dimethylaminoaxo-benzene derivative produced by rat liver enzymes.
    REGE DV; SREENIVASAN A
    Indian J Med Res; 1962 May; 50():502-7. PubMed ID: 14491057
    [No Abstract]   [Full Text] [Related]  

  • 8. ULTRASTRUCTURAL CHANGES IN THE RAT LIVER PRODUCED BY N-2-FLUORENYLDIACETAMIDE.
    MIKATA A; LUSE SA
    Am J Pathol; 1964 Mar; 44(3):455-79. PubMed ID: 14126666
    [No Abstract]   [Full Text] [Related]  

  • 9. A note on the deacylation of the carcinogen 2-acetamidofluorene and related compounds by rat liver and intestine.
    NAGASAWA HT; GUTMANN HR
    Biochim Biophys Acta; 1957 Jul; 25(1):186-9. PubMed ID: 13445738
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell growth and the development of tumours.
    LAIRD AK; BARTON AD
    Nature; 1959 Jun; 183(4676):1655-7. PubMed ID: 13666848
    [No Abstract]   [Full Text] [Related]  

  • 11. The metabolism of the carcinogen N-(2-fluorenyl) acetamide by liver cell fractions.
    SEAL US; GUTMANN HR
    J Biol Chem; 1959 Mar; 234(3):648-54. PubMed ID: 13641277
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of N-2-fluorenyldiacetamide induced hepatic carcinogenesis in rats by chloramphenicol: a dose-related phenomenon with reduced protein binding of carcinogen.
    Oster WF; Firminger HI; Morrison DM
    Yale J Biol Med; 1971; 43(4-5):297-306. PubMed ID: 4325376
    [No Abstract]   [Full Text] [Related]  

  • 13. [Glycogen and endoplasmic reticulum of the liver cell after high doses of the carcinogen N-nitrosomorpholin].
    Theodossiou A; Bannasch P; Reuss W
    Virchows Arch B Cell Pathol; 1971; 7(2):126-46. PubMed ID: 4323679
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of phenobarbital- and carcinogen-induced aldehyde dehydrogenases in the rat.
    Marselos M; Törrönen R; Koivula T; Koivusalo M
    Biochim Biophys Acta; 1979 Feb; 583(1):110-8. PubMed ID: 420867
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of diphosphopyridine nucleotide on the inhibition of rat liver 3-hydroxyanthranilic-acid oxidase by 2-acetylaminofluorene and N-2-fluorenyl-diacetamide.
    QUAGLIARIELLO E; AURICCHIO S; RINALDI E; RUBINO A
    Nature; 1958 Dec; 182(4651):1744. PubMed ID: 13622647
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inactivation of tissue-specific inhibitors by a carcinogen].
    Volm M; Kinzel V; Süss R
    Verh Dtsch Ges Pathol; 1969; 53():560-4. PubMed ID: 4190784
    [No Abstract]   [Full Text] [Related]  

  • 17. Choline oxidase activity in the hepatic tissue of rats fed on carcinogens.
    ASANO BI
    Gan; 1955 Mar; 46(1):41-6. PubMed ID: 14380578
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary metabolites of the carcinogen N-2-fluorenylacetamide.
    MORRIS HP; WEISBURGER EK; WEISBURGER JH
    J Natl Cancer Inst; 1956 Sep; 17(3):345-61. PubMed ID: 13367806
    [No Abstract]   [Full Text] [Related]  

  • 19. Chromatographic separation of some metabolites of the carcinogen N-2-fluorenylacetamide.
    MORRIS HP; SOBER HA; WEISBURGER EK; WEISBURGER JH
    J Natl Cancer Inst; 1956 Sep; 17(3):363-74. PubMed ID: 13367807
    [No Abstract]   [Full Text] [Related]  

  • 20. MORPHOLOGIC AND BIOLOGIC CORRELATION OF LESIONS OBTAINED IN HEPATIC CARCINOGENESIS IN A X C RATS GIVEN 0.025 PERCENT N-2-FLUORENYLDIACETAMIDE.
    REUBER MD; FIRMINGER HI
    J Natl Cancer Inst; 1963 Dec; 31():1407-29. PubMed ID: 14087658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.